Literature DB >> 23514609

Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide.

Frederick T Collison1, Mohamed A Genead, Gerald A Fishman, Edwin M Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23514609     DOI： 10.3109/13816810.2013.779383

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN： 1381-6810            Impact factor:   1.803


× No keyword cloud information.
  6 in total

1.  Efficacy of topical brinzolamide in children with retinal dystrophies.

Authors:  Brittni A Scruggs; Constance V Chen; Wanda Pfeifer; Jill S Wiley; Kai Wang; Arlene V Drack
Journal:  Ophthalmic Genet       Date:  2019-09-09       Impact factor: 1.803

2.  Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report.

Authors:  Ama Sadaka; Robert A Sisk
Journal:  J Med Case Rep       Date:  2016-06-01

3.  Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months.

Authors:  Mark E Pennesi; David G Birch; K Thiran Jayasundera; Maria Parker; Ou Tan; Rabia Gurses-Ozden; Carrie Reichley; Kathleen N Beasley; Paul Yang; Richard G Weleber; Lea D Bennett; John R Heckenlively; Kalyani Kothapalli; Jeffrey D Chulay
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

4.  Dramatic response to topical dorzolamide in X-linked retinoschisis.

Authors:  Rajeswari Thangavel; Abhidnya Surve; Shorya Azad; Vinod Kumar
Journal:  Indian J Ophthalmol       Date:  2020-07       Impact factor: 1.848

5.  Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population.

Authors:  Bohdan Kousal; Lucia Hlavata; Hana Vlaskova; Lenka Dvorakova; Michaela Brichova; Zora Dubska; Hana Langrova; Andrea L Vincent; Lubica Dudakova; Petra Liskova
Journal:  Genes (Basel)       Date:  2021-11-18       Impact factor: 4.096

6.  Rebound macular edema following oral acetazolamide therapy for juvenile X-linked retinoschisis in an Italian family.

Authors:  Maria Silvana Galantuomo; Maurizio Fossarello; Alberto Cuccu; Roberta Farci; Markus N Preising; Birgit Lorenz; Pietro Emanuele Napoli
Journal:  Clin Ophthalmol       Date:  2016-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.